{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:53Z","timestamp":1793407613588,"version":"4.5.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Swiss Heart Foundation"},{"name":"Swiss Working Group of Interventional Cardiology"},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Symetis"},{"name":"JenaValve"},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p\/>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>The SwissTAVI Registry includes all consecutive patients undergoing transcatheter aortic valve implantation (TAVI) and valve-in-valve (VinV) procedures for a failed bioprosthesis in Switzerland. We report the real world, all-comers, 30-day and 1-year outcomes of patients undergoing VinV and standard TAVI procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Prospectively collected data from the 2 groups (VinV and standard TAVI patients) were retrospectively analysed. In an adjusted analysis, in-hospital and 1-year outcomes of VinV patients were compared with those of patients undergoing TAVI for native aortic valve disease in the same registry. A subanalysis of VinV procedures in stenotic or regurgitant bioprosthesis was also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Between February 2011 and December 2016, 4599 and 157 consecutive patients underwent TAVI in native aortic valves and VinV procedures in degenerate bioprosthesis, respectively. VinV patients were younger (78\u2009\u00b1\u20099.1\u2009years vs 82.2\u2009\u00b1\u20096.3\u2009years; P\u2009&lt;\u20090.001) but at a higher risk for surgery (the logistic EuroSCORE: 28.48\u2009\u00b1\u200915.3% vs 18.2\u2009\u00b1\u200913.6%; P\u2009&lt;\u20090.001; the Society of Thoracic Surgery (STS) score: 6.4\u2009\u00b1\u20095% vs 5.5\u2009\u00b1\u20094.3%; P\u2009=\u20090.008). Valve predilatation was less frequently performed during VinV procedures (22.9% vs 69.1%; P\u2009&lt;\u20090.001), and the hospital stay was shorter after VinV procedure (8.46\u2009\u00b1\u20094.2\u2009days vs 9.83\u2009\u00b1\u20096\u2009days; P\u2009=\u20090.005). VinV patients showed higher predischarge transvalvular mean gradients (14.14\u2009\u00b1\u20097.9\u2009mmHg vs 8.42\u2009\u00b1\u20095.0\u2009mmHg; P\u2009&lt;\u20090.001), smaller mean valve surface area (1.54\u2009\u00b1\u20090.7\u2009cm2 vs 1.83\u2009\u00b1\u20090.5\u2009cm2; P\u2009&lt;\u20090.001) and a lower risk of moderate\/severe paravalvular leak (1.3% vs 5%). Post-procedural kidney injury (1.3% vs 4.8%; P\u2009=\u20090.06) and new pacemakers for conduction abnormalities (3.3% vs 18.5%; P\u2009&lt;\u20090.001) were higher after TAVI. All-cause mortality and cardiovascular mortality at 30 days were similar between the 2 groups (1.9% vs 3.8%; P\u2009=\u20090.242 and 1.9% vs 3.4%; P\u2009=\u20090.321), whereas after 1 year, all-cause mortality was lower for VinV patients (6.8% vs 13%; P\u2009=\u20090.035). The bioprosthetic valve size correlated inversely with postoperative gradients after VinV procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>VinV aortic procedures showed favourable 30-day and 1-year clinical outcomes compared with TAVI procedures for the native aortic valve disease. Despite higher transvalvular mean gradients following VinV implants, this appears not to impact the early clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejcts\/ezy471","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T23:17:13Z","timestamp":1545175033000},"page":"55-63","source":"Crossref","is-referenced-by-count":38,"title":["The hospital results and 1-year outcomes of transcatheter aortic valve-in-valve procedures and transcatheter aortic valve implantations in the native valves: the results from the Swiss-TAVI Registry"],"prefix":"10.1093","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2837-3242","authenticated-orcid":false,"given":"Enrico","family":"Ferrari","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Cardiocentro Ticino, Lugano, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stortecky","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dik","family":"Heg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lausanne University Hospital, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Nietlispach","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiovascular Surgery, Zurich University Hospital, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tueller","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Triemlispital, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Toggweiler","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cantonal Hospital, Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Noble","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Cardiovascular Surgery, Zurich University Hospital, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raban","family":"Jeger","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Basel University Hospital, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Gr\u00fcnenfelder","sequence":"additional","affiliation":[{"name":"Heart Clinic Hirslanden, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Huber","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Geneva University Hospital, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Swiss Cardiovascular Center, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wenaweser","sequence":"additional","affiliation":[{"name":"Heart Clinic Hirslanden, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,27]]},"reference":[{"key":"2019073110403143000_ezy471-B1","first-page":"314","article-title":"Transcatheter aortic valve implantation (TAVI) in 2018: recent advances and future development","volume":"66","author":"Hecker","year":"2018","journal-title":"Minerva Cardioangiol"},{"key":"2019073110403143000_ezy471-B2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/fca-2017-0056","article-title":"Transcatheter aortic valve implantation: where are we now?","volume":"13","author":"Mariathas","year":"2017","journal-title":"Future Cardiol"},{"key":"2019073110403143000_ezy471-B3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.21037\/acs.2017.08.02","article-title":"Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: results of self-expandable and balloon-expandable transcatheter heart valves","volume":"6","author":"Tarantini","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2019073110403143000_ezy471-B4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4244\/EIJV10I8A166","article-title":"Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry","volume":"10","author":"Wenaweser","year":"2014","journal-title":"EuroIntervention"},{"key":"2019073110403143000_ezy471-B5","doi-asserted-by":"crossref","first-page":"e002653","DOI":"10.1161\/CIRCINTERVENTIONS.115.002653","article-title":"Procedural results and clinical outcomes of transcatheter aortic valve implantation in Switzerland: an observational cohort study of Sapien 3 versus Sapien XT transcatheter heart valves","volume":"8","author":"Binder","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2019073110403143000_ezy471-B6","first-page":"260","article-title":"Transcatheter aortic \u201cvalve-in-valve\u201d for degenerated bioprostheses: choosing the right TAVI valve","volume":"1","author":"Ferrari","year":"2012","journal-title":"Ann Cardiothorac Surg"},{"key":"2019073110403143000_ezy471-B7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves","volume":"312","author":"Dvir","year":"2014","journal-title":"JAMA"},{"key":"2019073110403143000_ezy471-B8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17434440.2016.1207521","article-title":"Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves","volume":"13","author":"Gallo","year":"2016","journal-title":"Expert Rev Med Devices"},{"key":"2019073110403143000_ezy471-B9","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.jacc.2017.02.057","article-title":"Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry","volume":"69","author":"Webb","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2019073110403143000_ezy471-B10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/icvts\/ivv053","article-title":"Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series","volume":"20","author":"Huber","year":"2015","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2019073110403143000_ezy471-B11","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2019073110403143000_ezy471-B12","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/heartjnl-2017-312422","article-title":"Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve","volume":"104","author":"Bleiziffer","year":"2018","journal-title":"Heart"},{"key":"2019073110403143000_ezy471-B13","article-title":"Transaortic transcatheter aortic valve replacement through a right mini-thoracotomy with balloon-expandable SapienTM 3 valve","volume":"2016","author":"Ferrari","year":"2016","journal-title":"Multimed Man Cardiothorac Surg"},{"key":"2019073110403143000_ezy471-B14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13019-017-0638-9","article-title":"Hospital outcome and risk factor analysis of transapical versus transfemoral approach for transcatheter aortic valve replacement","volume":"12","author":"Ferrari","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"2019073110403143000_ezy471-B15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/icvts\/ivw433","article-title":"Apical closure device for full-percutaneous transapical valve implantation: stress-test in an animal model","volume":"24","author":"Ferrari","year":"2017","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2019073110403143000_ezy471-B16","doi-asserted-by":"crossref","first-page":"w14237.","DOI":"10.4414\/smw.2016.14237","article-title":"Apical access and closure devices for transapical transcatheter heart valve procedures","volume":"146","author":"Ferrari","year":"2016","journal-title":"Swiss Med Wkly"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezy471\/28648031\/ezy471.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ejcts\/article-pdf\/56\/1\/55\/29024597\/ezy471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:18:20Z","timestamp":1775319500000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/56\/1\/55\/5303209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,27]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,27]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezy471","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,1,27]]}}}